An assessment of survival outcomes among ovarian cancer patients at the National and Referral Hospital in Kenya

Abstract Background Ovarian cancer has been shown to have poor survival outcomes attributed to late presentation. In Kenya, information on the survival outcomes of ovarian cancer patients is scarce. Therefore, the objective of this study was to examine the survival outcomes among patients with ovari...

Full description

Bibliographic Details
Main Authors: Diana Bironga Mayenga, Amsalu Degu
Format: Article
Language:English
Published: Wiley 2024-02-01
Series:Cancer Reports
Subjects:
Online Access:https://doi.org/10.1002/cnr2.1986
_version_ 1797292528466132992
author Diana Bironga Mayenga
Amsalu Degu
author_facet Diana Bironga Mayenga
Amsalu Degu
author_sort Diana Bironga Mayenga
collection DOAJ
description Abstract Background Ovarian cancer has been shown to have poor survival outcomes attributed to late presentation. In Kenya, information on the survival outcomes of ovarian cancer patients is scarce. Therefore, the objective of this study was to examine the survival outcomes among patients with ovarian cancer treated at Kenyatta National Hospital (KNH). Aims A hospital‐based retrospective cohort study was performed at KNH to examine the survival outcomes of 112 ovarian cancer patients. The study employed a structured data abstraction tool to acquire patients' relevant socio‐demographic and clinical characteristics from the patient's medical records. The data obtained were analyzed using SPSS version 29.0 statistical software. Kaplan–Meier and Cox regression analyses were used to determine the survival outcome and predictors of mortality among ovarian cancer patients, respectively. Methods and results The mean age of the patients in this study was 51.28 ± 14.24 years. Most patients (59.8%) had evidence of distant metastasis during the follow‐up period. One‐third (33%) of patients were deceased. The mean‐cancer‐specific survival time among the study participants was 40.0 ± 3.0 months. The 5‐year survival rate was 44%, with most patients experiencing disease progression during the last follow‐up. Combination therapy (p < .001) was the only statistically significant predictor of mortality in ovarian cancer patients. Conclusion The study found that the 5‐year survival rate among ovarian cancer patients was poor, with most patients experiencing disease progression during the last follow‐up period.
first_indexed 2024-03-07T19:57:44Z
format Article
id doaj.art-159e12a3bbd34cb7bd55ce0044517908
institution Directory Open Access Journal
issn 2573-8348
language English
last_indexed 2024-03-07T19:57:44Z
publishDate 2024-02-01
publisher Wiley
record_format Article
series Cancer Reports
spelling doaj.art-159e12a3bbd34cb7bd55ce00445179082024-02-28T13:54:58ZengWileyCancer Reports2573-83482024-02-0172n/an/a10.1002/cnr2.1986An assessment of survival outcomes among ovarian cancer patients at the National and Referral Hospital in KenyaDiana Bironga Mayenga0Amsalu Degu1School of Pharmacy and Health Sciences, Department of Pharmaceutics and Pharmacy Practice United States International University‐Africa Nairobi KenyaSchool of Pharmacy and Health Sciences, Department of Pharmaceutics and Pharmacy Practice United States International University‐Africa Nairobi KenyaAbstract Background Ovarian cancer has been shown to have poor survival outcomes attributed to late presentation. In Kenya, information on the survival outcomes of ovarian cancer patients is scarce. Therefore, the objective of this study was to examine the survival outcomes among patients with ovarian cancer treated at Kenyatta National Hospital (KNH). Aims A hospital‐based retrospective cohort study was performed at KNH to examine the survival outcomes of 112 ovarian cancer patients. The study employed a structured data abstraction tool to acquire patients' relevant socio‐demographic and clinical characteristics from the patient's medical records. The data obtained were analyzed using SPSS version 29.0 statistical software. Kaplan–Meier and Cox regression analyses were used to determine the survival outcome and predictors of mortality among ovarian cancer patients, respectively. Methods and results The mean age of the patients in this study was 51.28 ± 14.24 years. Most patients (59.8%) had evidence of distant metastasis during the follow‐up period. One‐third (33%) of patients were deceased. The mean‐cancer‐specific survival time among the study participants was 40.0 ± 3.0 months. The 5‐year survival rate was 44%, with most patients experiencing disease progression during the last follow‐up. Combination therapy (p < .001) was the only statistically significant predictor of mortality in ovarian cancer patients. Conclusion The study found that the 5‐year survival rate among ovarian cancer patients was poor, with most patients experiencing disease progression during the last follow‐up period.https://doi.org/10.1002/cnr2.1986Kenyatta National Hospitalovarian cancersurvival outcomes
spellingShingle Diana Bironga Mayenga
Amsalu Degu
An assessment of survival outcomes among ovarian cancer patients at the National and Referral Hospital in Kenya
Cancer Reports
Kenyatta National Hospital
ovarian cancer
survival outcomes
title An assessment of survival outcomes among ovarian cancer patients at the National and Referral Hospital in Kenya
title_full An assessment of survival outcomes among ovarian cancer patients at the National and Referral Hospital in Kenya
title_fullStr An assessment of survival outcomes among ovarian cancer patients at the National and Referral Hospital in Kenya
title_full_unstemmed An assessment of survival outcomes among ovarian cancer patients at the National and Referral Hospital in Kenya
title_short An assessment of survival outcomes among ovarian cancer patients at the National and Referral Hospital in Kenya
title_sort assessment of survival outcomes among ovarian cancer patients at the national and referral hospital in kenya
topic Kenyatta National Hospital
ovarian cancer
survival outcomes
url https://doi.org/10.1002/cnr2.1986
work_keys_str_mv AT dianabirongamayenga anassessmentofsurvivaloutcomesamongovariancancerpatientsatthenationalandreferralhospitalinkenya
AT amsaludegu anassessmentofsurvivaloutcomesamongovariancancerpatientsatthenationalandreferralhospitalinkenya
AT dianabirongamayenga assessmentofsurvivaloutcomesamongovariancancerpatientsatthenationalandreferralhospitalinkenya
AT amsaludegu assessmentofsurvivaloutcomesamongovariancancerpatientsatthenationalandreferralhospitalinkenya